Edwin Donnelly, MD, PHD

NPI: 1215029632
Total Payments
$27,635
2024 Payments
$1,520
Companies
3
Transactions
19
Medicare Patients
13,732
Medicare Billing
$301,592

Payment Breakdown by Category

Consulting$15,557 (56.3%)
Other$10,560 (38.2%)
Travel$1,267 (4.6%)
Food & Beverage$251.28 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $15,557 10 56.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,560 4 38.2%
Travel and Lodging $1,267 2 4.6%
Food and Beverage $251.28 3 0.9%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca UK Limited $15,557 10 $0 (2024)
Genentech USA, Inc. $9,393 8 $0 (2020)
AstraZeneca Pharmaceuticals LP $2,685 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,520 2 AstraZeneca UK Limited ($1,520)
2023 $10,278 6 AstraZeneca UK Limited ($10,278)
2022 $3,759 2 AstraZeneca Pharmaceuticals LP ($2,685)
2021 $2,685 1 AstraZeneca UK Limited ($2,685)
2020 $396.90 1 Genentech USA, Inc. ($396.90)
2019 $8,996 7 Genentech USA, Inc. ($8,996)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/30/2024 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $1,074.00 General
02/29/2024 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $445.71 General
11/06/2023 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $1,755.99 General
08/04/2023 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $1,970.79 General
06/23/2023 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $268.50 General
06/19/2023 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $4,027.50 General
03/28/2023 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $912.90 General
03/14/2023 AstraZeneca UK Limited ENHERTU (Biological) Consulting Fee Cash or cash equivalent $1,342.50 General
Category: Oncology
12/13/2022 AstraZeneca Pharmaceuticals LP TAGRISSO (Drug) Consulting Fee Cash or cash equivalent $2,685.00 General
Category: Oncology
05/16/2022 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $1,074.00 General
07/06/2021 AstraZeneca UK Limited Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,685.00 General
03/25/2020 Genentech USA, Inc. Travel and Lodging Cash or cash equivalent $396.90 General
12/09/2019 Genentech USA, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,875.00 General
12/09/2019 Genentech USA, Inc. Food and Beverage In-kind items and services $114.57 General
12/03/2019 Genentech USA, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
10/30/2019 Genentech USA, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,600.00 General
10/30/2019 Genentech USA, Inc. Travel and Lodging Cash or cash equivalent $870.10 General
10/30/2019 Genentech USA, Inc. Food and Beverage In-kind items and services $88.47 General
06/18/2019 Genentech USA, Inc. Xolair (Biological), Esbriet Food and Beverage In-kind items and services $48.24 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 3,134 4,419 $284,320 $53,234
2022 6 3,353 4,298 $341,660 $66,055
2021 6 3,496 4,534 $405,785 $82,129
2020 8 3,749 6,651 $517,481 $100,175
Total Patients
13,732
Total Services
19,902
Medicare Billing
$301,592
Procedure Codes
40

All Medicare Procedures & Services

40 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
71045 X-ray of chest, 1 view Facility 2023 1,564 2,803 $112,120 $19,199 17.1%
71260 Ct scan of chest with contrast Office 2023 156 161 $33,810 $6,509 19.3%
71275 Ct scan of blood vessels of chest with contrast Facility 2023 87 89 $28,925 $5,946 20.6%
71260 Ct scan of chest with contrast Facility 2023 121 121 $25,410 $5,050 19.9%
71046 X-ray of chest, 2 views Office 2023 604 620 $24,800 $4,633 18.7%
71250 Ct scan of chest without contrast Facility 2023 114 117 $22,815 $4,615 20.2%
71250 Ct scan of chest without contrast Office 2023 87 88 $17,160 $3,322 19.4%
71046 X-ray of chest, 2 views Facility 2023 385 404 $16,160 $3,146 19.5%
71271 Low dose ct scan of chest for lung cancer screening Office 2023 16 16 $3,120 $815.36 26.1%
71045 X-ray of chest, 1 view Facility 2022 1,479 2,354 $94,030 $16,268 17.3%
71260 Ct scan of chest with contrast Office 2022 269 281 $56,200 $10,640 18.9%
71260 Ct scan of chest with contrast Facility 2022 212 220 $44,000 $8,924 20.3%
71250 Ct scan of chest without contrast Facility 2022 195 200 $37,990 $7,821 20.6%
71250 Ct scan of chest without contrast Office 2022 184 185 $35,145 $6,924 19.7%
71275 Ct scan of blood vessels of chest with contrast Facility 2022 94 96 $30,715 $6,551 21.3%
71046 X-ray of chest, 2 views Office 2022 473 480 $19,200 $3,648 19.0%
71046 X-ray of chest, 2 views Facility 2022 413 448 $17,920 $3,512 19.6%
71271 Low dose ct scan of chest for lung cancer screening Office 2022 34 34 $6,460 $1,768 27.4%
71260 Diagnostic ct scan of chest with contrast Office 2021 422 470 $94,000 $19,380 20.6%
71045 X-ray of chest, 1 view Facility 2021 1,493 2,407 $84,245 $17,110 20.3%
71260 Diagnostic ct scan of chest with contrast Facility 2021 288 302 $60,400 $12,633 20.9%
71250 Diagnostic ct scan of chest Facility 2021 231 241 $44,585 $9,487 21.3%
71275 Ct scan of blood vessels in chest with contrast Facility 2021 117 120 $37,800 $8,185 21.7%
71250 Diagnostic ct scan of chest Office 2021 194 199 $36,815 $7,737 21.0%
71046 X-ray of chest, 2 views Facility 2021 367 405 $16,200 $3,245 20.0%

About Edwin Donnelly, MD, PHD

Edwin Donnelly, MD, PHD is a Diagnostic Radiology healthcare provider based in Powell, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215029632.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edwin Donnelly, MD, PHD has received a total of $27,635 in payments from pharmaceutical and medical device companies, with $1,520 received in 2024. These payments were reported across 19 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($15,557).

As a Medicare-enrolled provider, Donnelly has provided services to 13,732 Medicare beneficiaries, totaling 19,902 services with total Medicare billing of $301,592. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.

Practice Information

  • Specialty Diagnostic Radiology
  • Location Powell, OH
  • Active Since 09/30/2006
  • Last Updated 08/26/2025
  • Taxonomy Code 2085R0202X
  • Entity Type Individual
  • NPI Number 1215029632

Products in Payments

  • TAGRISSO (Drug) $2,685
  • ENHERTU (Biological) $1,343
  • Xolair (Biological) $48.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Diagnostic Radiology Doctors in Powell